The strong beat-and-raise quarter confirms the company's operating leverage thesis. Monitor the Q3 guidance midpoint for adjusted EBITDA ($20-$30M) which implies a seasonal step-down from Q2's $68.1M, but the full-year raise to $145-$163M suggests confidence in H2 execution.
Price Chart
Executive Summary
Alignment Healthcare reported Q2 2026 results that surpassed the high end of guidance across all key metrics, with total revenue of $1.336B (+31.6% YoY) and GAAP diluted EPS of $0.17. The company raised the midpoint of all full-year guidance metrics, including revenue to $5.195-$5.225B and adjusted EBITDA to $145-$163M, signaling continued strong execution and margin expansion in its Medicare Advantage platform.
Key Financial Metrics
Key Facts
- Total revenue of $1.336B, up 31.6% YoY, surpassing the high end of guidance
- GAAP diluted EPS of $0.17 vs $0.07 in the prior year quarter
- Adjusted EBITDA of $68.1M, up 48.4% YoY, with margin expanding to 5.1%
- Medical benefits ratio improved ~40 bps YoY to 86.3%
- Raised midpoint of all full-year guidance: revenue to $5.195-$5.225B, adjusted EBITDA to $145-$163M
- Medicare Advantage membership grew 31.5% YoY to ~294,100 members
Financial Impact
Revenue beat consensus by ~2% ($1.336B vs $1.31B est); EPS of $0.17 vs $0.13 consensus represents a ~31% beat; full-year guidance raised across all metrics
Risk Factors
- Potential federal reductions in Medicare Advantage funding could pressure future margins
- Seasonal step-down in Q3 adjusted EBITDA guidance ($20-$30M) may cause near-term volatility
- Insider selling of $10.2M in the past 30 days could signal caution at elevated prices
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-005078 |
| Document: f8k_073026.htm | 0001171843-26-005078 |
| Document: 0001171843-26-005078-index-headers.html | 0001171843-26-005078 |
| Document: 0001171843-26-005078-index.html | 0001171843-26-005078 |
| Document: 0001171843-26-005078.txt | 0001171843-26-005078 |
| 8-K Data (Synthetic) | 0001171843-26-005078 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | Institutional Cluster | $8.44 $8.43 | ▼ −0.12% | ▲ +1.06% | $8.05 (−4.62%) |
Oct 19, 2026 8d ago | Press Release | $8.40 $8.51 | ▲ +1.31% | ▲ +0.97% | $8.05 (−4.17%) |
Oct 8, 2026 19d ago | 8-K | $7.55 $8.09 | ▼ −7.22% | ▼ −7.28% | $8.05 (−6.69%) |
Oct 5, 2026 22d ago | SC 13G/A | $8.50 $8.37 | ▼ −1.53% | ▼ −2.08% | $8.05 (−5.29%) |
Sep 18, 2026 5w ago | Insider Cluster | $8.33 $7.99 | ▲ +4.08% | ▲ +4.07% | $8.05 (+3.36%) |
Sep 16, 2026 5w ago | Insider Cluster | $8.70 $8.35 | ▲ +4.02% | ▲ +3.90% | $8.05 (+7.47%) |
Sep 16, 2026 5w ago | 144 | $8.70 $8.35 | ▼ −4.02% | ▼ −3.90% | $8.05 (−7.47%) |
Sep 11, 2026 6w ago | Insider Cluster | $12.94 $10.37 | ▲ +19.86% | ▲ +19.40% | $8.05 (+37.79%) |
Sep 9, 2026 6w ago | 144 | $12.76 $12.61 | ▼ −1.18% | ▼ −2.03% | $8.05 (−36.91%) |
Aug 5, 2026 11w ago | Institutional Cluster | $13.38 $14.37 | ▲ +7.40% | ▲ +6.79% | $8.05 (−39.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers